Meanwhile, we have previously shown that ACS patients had notably lower plasma PEDF level relative to the control group and lower PEDF level was further related to adverse cardiac outcomes after ACS [19], and that PEDF level remarkably decreased in CAD patients compared to the controls [20]. The gene discussed is SERPINF1; the disease is coronary artery disorder.